Literature DB >> 25572252

Molecular and genetic basis of depression.

Madhumita Roy1, Madhu G Tapadia, Shobhna Joshi, Biplob Koch.   

Abstract

Joyousness or sadness is normal reaction to state of life. If any of these lead to certain semi-permanent changes in daily life, then it is termed as mental disorder. Depression is one of the mental disorders with a state of low mood and aversion to activities that exerts a negative effect on a person's thoughts and behaviour. Adolescent group is probably the world's largest active group of people, who are getting prone to this state of mind leading to their diminished mental and physical abilities. Depression is closely linked to stress and thus a chronic stressful life can increase the risk of depression. Depression is a complex disease having both genetic and environmental components as contributing factors. In this study an attempt has been made to put forward the understanding of the known genes and their functional relationships with depression and stress with special reference to BDNF and 5-HTTLPR. Analysis of common genetic variants associated with depression, especially in the members of a family who had a previous history, might help in identifying the individuals at risk prior to the onset of depression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25572252     DOI: 10.1007/s12041-014-0449-x

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  195 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 2.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

3.  Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depression.

Authors:  K P Lesch; S Jatzke; J Meyer; G Stöber; O Okladnova; R Mössner; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

4.  Association between 1603C>T polymorphism of DBH gene and bipolar disorder in a Turkish population.

Authors:  Omer Ates; Feryal Cam Celikel; Serap Erdogan Taycan; Saime Sezer; Nevin Karakus
Journal:  Gene       Date:  2013-02-04       Impact factor: 3.688

5.  Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR).

Authors:  Beverly H Brummett; Stephen H Boyle; Ilene C Siegler; Cynthia M Kuhn; Allison Ashley-Koch; Charles R Jonassaint; Stephan Züchner; Ann Collins; Redford B Williams
Journal:  Behav Genet       Date:  2007-10-23       Impact factor: 2.805

Review 6.  Role of neurotrophic factors in the etiology and treatment of mood disorders.

Authors:  Ronald S Duman
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

7.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  Increased waking salivary cortisol levels in young people at familial risk of depression.

Authors:  Zola N Mannie; Catherine J Harmer; Philip J Cowen
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

10.  Genomic view of bipolar disorder revealed by whole genome sequencing in a genetic isolate.

Authors:  Benjamin Georgi; David Craig; Rachel L Kember; Wencheng Liu; Ingrid Lindquist; Sara Nasser; Christopher Brown; Janice A Egeland; Steven M Paul; Maja Bućan
Journal:  PLoS Genet       Date:  2014-03-13       Impact factor: 5.917

View more
  8 in total

Review 1.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

Review 2.  Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression.

Authors:  Shih-Jen Tsai
Journal:  Oncotarget       Date:  2017-08-04

3.  In silico analysis of the V66M variant of human BDNF in psychiatric disorders: An approach to precision medicine.

Authors:  Clara Carolina Silva De Oliveira; Gabriel Rodrigues Coutinho Pereira; Jamile Yvis Santos De Alcantara; Deborah Antunes; Ernesto Raul Caffarena; Joelma Freire De Mesquita
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

4.  Transcriptomics and sequencing analysis of gene expression profiling for major depressive disorder.

Authors:  Pragya Verma; Madhvi Shakya
Journal:  Indian J Psychiatry       Date:  2021-12-03       Impact factor: 1.759

Review 5.  Neuroimmune crosstalk through brain-derived neurotrophic factor and its precursor pro-BDNF: New insights into mood disorders.

Authors:  Xiao-Pei Zhao; Hui Li; Ru-Ping Dai
Journal:  World J Psychiatry       Date:  2022-03-19

6.  Depression and Inflammatory Periodontal Disease Considerations-An Interdisciplinary Approach.

Authors:  Alexandrina L Dumitrescu
Journal:  Front Psychol       Date:  2016-03-23

Review 7.  Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease.

Authors:  Serena Silvestro; Giovanni Schepici; Placido Bramanti; Emanuela Mazzon
Journal:  Molecules       Date:  2020-11-07       Impact factor: 4.411

Review 8.  The Brain-Skin Axis in Psoriasis-Psychological, Psychiatric, Hormonal, and Dermatological Aspects.

Authors:  Luiza Marek-Jozefowicz; Rafał Czajkowski; Alina Borkowska; Bogusław Nedoszytko; Michał A Żmijewski; Wiesław J Cubała; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.